Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1.87% is 52% above its 5-year average of -3.90%, around the middle of its 5-year range (-21.05%–26.38%).
15.70% above its 12-month average of -2.22%.
Reported quarterly profit margin; no daily interpolation. Q1 FY2027 (2026-07-31): -2.80%.
NET PROFIT MARGIN
-1.87%
NET PROFIT MARGIN AVG TTM
-2.22%
NET PROFIT MARGIN AVG 3Y
-3.46%
NET PROFIT MARGIN AVG 5Y
-3.90%
NET PROFIT MARGIN AVG 10Y
-4.47%
NET PROFIT MARGIN AVG 15Y
-35.12%
NET PROFIT MARGIN AVG 20Y
-35.26%
CURRENT VS TTM AVG
+15.70%
CURRENT VS 3Y AVG
+45.95%
CURRENT VS 5Y AVG
+52.10%
CURRENT VS 10Y AVG
+58.19%
CURRENT VS 15Y AVG
+94.68%
CURRENT VS 20Y AVG
+94.70%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 720 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Champions Oncology, Inc.
Market Cap
$67.80M
Net Profit Margin
-1.87%
TTM Avg
-2.22%
3Y Avg
-3.46%
5Y Avg
-3.90%
Market Cap
$68.17M
Net Profit Margin
-33044.00%
TTM Avg
-18819.13%
3Y Avg
-12177.01%
5Y Avg
-8726.92%
Market Cap
$68.76M
Net Profit Margin
163.32%
TTM Avg
-34.49%
3Y Avg
-63.76%
5Y Avg
-75.19%
Market Cap
$66.45M
Net Profit Margin
-621.71%
TTM Avg
-10746.07%
3Y Avg
-5373.04%
5Y Avg
-3582.02%
Market Cap
$65.57M
Net Profit Margin
-235.00%
TTM Avg
-200.38%
3Y Avg
-100.19%
5Y Avg
-66.80%
Market Cap
$70.25M
Net Profit Margin
-105.29%
TTM Avg
-106.48%
3Y Avg
-112.00%
5Y Avg
-95.88%
Market Cap
$63.78M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2871.11%
5Y Avg
-2144.71%
Market Cap
$63.69M
Net Profit Margin
-22.52%
TTM Avg
-11.22%
3Y Avg
-69.63%
5Y Avg
-131.75%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Champions Oncology, Inc. (CSBR) | $67.80M | -1.87% | -2.22% | -3.46% | -3.90% |
| iBio, Inc. (IBIO)vs › | $68.17M | -33044.00% | -18819.13% | -12177.01% | -8726.92% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.76M | 163.32% | -34.49% | -63.76% | -75.19% |
| RenovoRx, Inc. (RNXT)vs › | $66.45M | -621.71% | -10746.07% | -5373.04% | -3582.02% |
| Cingulate Inc. (CING)vs › | $66.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.57M | -235.00% | -200.38% | -100.19% | -66.80% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.25M | -105.29% | -106.48% | -112.00% | -95.88% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | -2871.11% | -2144.71% |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.69M | -22.52% | -11.22% | -69.63% | -131.75% |
| InterCure Ltd. (INCR)vs › | $63.61M | -13.72% | -20.80% | -11.88% | -17.10% |
Operating Margin
-1.7%
Net Profit Margin
-1.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-31 | -2.80% |
| 2026-04-30 | -5.27% |
| 2026-01-31 | -1.68% |
| 2025-10-31 | 1.99% |
| 2025-07-31 | -3.33% |
| 2025-04-30 | -14.85% |
| 2025-01-31 | 26.38% |
| 2024-10-31 | 5.40% |
| 2024-07-31 | 9.34% |
| 2024-04-30 | -0.78% |
| 2024-01-31 | -21.05% |
| 2023-10-31 | -17.90% |
| 2023-07-31 | -20.43% |
| 2023-04-30 | -19.59% |
| 2023-01-31 | -19.09% |
| 2022-10-31 | -0.11% |
| 2022-07-31 | -2.32% |
| 2022-04-30 | -2.67% |
| 2022-01-31 | 5.97% |
| 2021-10-31 | 2.35% |
| 2021-07-31 | -1.53% |
| 2021-04-30 | -4.30% |
| 2021-01-31 | 8.87% |
| 2020-10-31 | 0.01% |
| 2020-07-31 | 0.79% |
| 2020-04-30 | -23.40% |
| 2020-01-31 | 4.52% |
| 2019-10-31 | 4.03% |
| 2019-07-31 | -9.51% |
| 2019-04-30 | -3.28% |
| 2019-01-31 | -5.74% |
| 2018-10-31 | 3.99% |
| 2018-07-31 | 7.74% |
| 2018-04-30 | -12.84% |
| 2018-01-31 | -1.50% |
| 2017-10-31 | -1.81% |
| 2017-07-31 | -13.39% |
| 2017-04-30 | -65.16% |
| 2017-01-31 | -39.52% |
| 2016-10-31 | -11.31% |
| 2016-07-31 | -69.37% |
| 2016-04-30 | -90.73% |
| 2016-01-31 | -94.51% |
| 2015-10-31 | -85.76% |
| 2015-07-31 | -103.22% |
| 2015-04-30 | -113.45% |
| 2015-01-31 | -153.96% |
| 2014-10-31 | -163.55% |
| 2014-07-31 | -185.56% |
| 2014-04-30 | -92.43% |
| 2014-01-31 | -15.56% |
| 2013-10-31 | -97.27% |
| 2013-07-31 | -73.91% |
| 2013-04-30 | -111.07% |
| 2013-01-31 | -33.94% |
| 2012-10-31 | -135.39% |
| 2012-07-31 | -62.82% |
| 2012-04-30 | -184.65% |
| 2012-01-31 | -71.74% |
| 2011-10-31 | -134.92% |
| 2011-07-31 | -124.66% |
| 2011-04-30 | -177.59% |
| 2011-01-31 | -14.80% |
| 2010-10-31 | -5.79% |
| 2010-07-31 | -36.94% |
| 2010-04-30 | -29.05% |
| 2010-01-31 | -105.66% |
| 2009-10-31 | -45.31% |
| 2009-07-31 | -104.26% |
| 2009-04-30 | -129.68% |
| 2009-01-31 | -57.22% |
| 2008-10-31 | -22.18% |
| 2008-07-31 | -19.47% |
| 2008-04-30 | -194.81% |
| 2008-01-31 | 66.06% |
| 2007-10-31 | 0.00% |
| 2007-07-31 | 3.43% |
| 2007-04-30 | 0.00% |
| 2007-01-31 | 0.00% |
| 2006-10-31 | 0.00% |
| 2006-07-31 | 0.00% |
| 2006-04-30 | 0.00% |
| 2006-01-31 | 0.00% |
| 2005-10-31 | 0.00% |
| 2005-07-31 | 0.00% |
| 2005-04-30 | 0.84% |
| 2005-01-31 | -18.61% |
| 2004-10-31 | -22.72% |
| 2004-07-31 | -15.16% |
| 2004-04-30 | 1.56% |
| 2004-01-31 | -11.68% |
| 2003-10-31 | -7.06% |
| 2003-07-31 | -8.72% |
| 2003-04-30 | -13.11% |
| 2003-01-31 | -9.57% |
| 2002-10-31 | 6.67% |
